NewAmsterdam Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAMS and other ETFs, options, and stocks.

About NAMS

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. 

CEO
Michael H. Davidson
CEOMichael H. Davidson
Employees
68
Employees68
Headquarters
Naarden, Noord-Holland
HeadquartersNaarden, Noord-Holland
Founded
2022
Founded2022
Employees
68
Employees68

NAMS Key Statistics

Market cap
2.00B
Market cap2.00B
Price-Earnings ratio
-7.01
Price-Earnings ratio-7.01
Dividend yield
Dividend yield
Average volume
1.28M
Average volume1.28M
High today
$18.66
High today$18.66
Low today
$17.64
Low today$17.64
Open price
$18.50
Open price$18.50
Volume
1.43M
Volume1.43M
52 Week high
$27.29
52 Week high$27.29
52 Week low
$15.19
52 Week low$15.19

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.